The U.S. Securities and Exchange Commission said on Thursday that it charged Cassava Sciences and two of the company's former ...

Researcher Gary Gibson talks at Burke in White Plains about a trial on a new treatment for Alzheimer’s that uses Benfotiamine ...

The "Delirium - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering."Delirium - Global Clinical Trials Review, 2024" provides an overview of ...

The "Cystic Fibrosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of Cystic Fibrosis ...

Prostate cancer disproportionately affects Black men, leading to higher mortality rates and worse health outcomes compared to ...

Shares of Cassava Sciences fell 10% in post-market trading on Thursday after the U.S. Securities and Exchange Commission ...

This trial also includes an open-label portion for adults with type 1 diabetes up to 15 years since diagnosis. The open-label portion (n=40) is examining the efficacy, safety, and durability of ...

In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on Enanta Pharmaceuticals (ENTA – Research Report), ...

The NIH called the first phase of the initiative Researching COVID to Enhance Recovery (RECOVER). Its newest project will be ...

Vivani Medical today announced that Australian authorities approved a first-in-human clinical trial for its subdermal GLP-1 ...